Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

Published:2010-11-19 Issue:2 Volume:25 Page:254-258
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Waanders E,van der Velden V H J,van der Schoot C E,van Leeuwen F N,van Reijmersdal S V,de Haas V,Veerman A J,van Kessel A Geurts,Hoogerbrugge P M,Kuiper R P,van Dongen J J M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010275.pdf

Reference20 articles.

1. Veerman AJ, Kamps WA, van den Berg H, van den Berg E, Bokkerink JP, Bruin MC et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004). Lancet Oncol 2009; 10: 957–966.

2. Dongen van JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731–1738.

3. Velden van der VHJ, Corral L, Valsecchi MG, Jansen MW, De LP, Cazzaniga G et al. Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia 2009; 23: 1073–1079.

4. Flohr T, Schrauder A, Cazzaniga G, Panzer-Grumayer R, Velden van der VHJ, Fischer S et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771–782.

5. Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 2008; 111: 5477–5485.

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia;BMC Cancer;2024-08-29

2. IKZF1 in acute lymphoblastic leukemia: the rise before the fall?;Leukemia & Lymphoma;2024-08-29

3. Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia;2024-07-18

4. IKZF1 and BTG1 silencing reduces glucocorticoid response in B-cell precursor acute leukemia cell line;Hematology, Transfusion and Cell Therapy;2024-07

5. Multifaceted roles of IKZF1 gene, perspectives from bench to bedside;Frontiers in Oncology;2024-06-24